Truist raised the firm’s price target on Omega Healthcare (OHI) to $39 from $38 and keeps a Hold rating on the shares. The firm is adjusting its model, assuming $600M of acquisitions in 2025 and $106M of dispositions. Truist also assumes $524 million of equity issuance in 2025 with proceeds applied toward repaying $400 million of maturing unsecured notes and $231 million of secured debt.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target lowered to $41 from $43 at Wells Fargo
- Omega Healthcare price target lowered to $39 from $43 at RBC Capital
- Omega Healthcare Reports Strong 2024 Financial Results
- Omega Healthcare’s Balanced Earnings Call Highlights
- Strong Q4 Performance and Strategic Moves Reinforce Buy Rating for Omega Healthcare